Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

The Oncology Institute, Inc. (TOI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.4700+0.0600 (+4.26%)
At close: 04:00PM EST
1.5500 +0.08 (+5.44%)
After hours: 07:29PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.4100
Open1.4000
Bid1.4300 x 1400
Ask1.5500 x 2200
Day's Range1.3800 - 1.7200
52 Week Range1.3700 - 12.6600
Volume471,666
Avg. Volume190,417
Market Cap109.647M
Beta (5Y Monthly)1.84
PE Ratio (TTM)N/A
EPS (TTM)-602.0870
Earnings DateNov 09, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.50
  • GlobeNewswire

    The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa

    TOI continues expansion in South FloridaCERRITOS, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced its entrance into Miami-Dade County, Florida with the acquisition of Hematology/Oncology Associates of Miami and the addition of a Senior Medical Director for Florida, further strengthening their investment in South Florida. Dr. Roberto Ochoa, former National Director, Hemat

  • GlobeNewswire

    The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance

    CERRITOS, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today reported financial results for its third quarter ended September 30, 2022. Recent Operational Highlights Completed a $110 million strategic investment from Deerfield Management Company, L.P. through secured senior convertible notes on August 9, 2022Increased market count to 14 during the third quarter, including three

  • GlobeNewswire

    The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference

    CERRITOS, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, and its Chief Financial Officer, Mihir Shah, will participate in the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes on Thursday, November 10. About The Oncology Institute, Inc. Founded in 2007, TOI is advancing oncology by delivering highly special

Advertisement
Advertisement